This inventor holds 1 USPTO granted patent. Top assignee: Axxonis Pharma Ag. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Sven Jaenichen: Innovator in Migraine Treatment
Introduction
Sven Jaenichen is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of migraines. His innovative approach has led to the development of a unique patent that addresses a common yet debilitating condition.
Latest Patents
Sven Jaenichen holds a patent for "Methods of using 1-allyl ergot alkaloid derivatives to treat migraines." This invention relates to 1-allyl ergot alkaloids and their derivatives, which possess selective antagonistic properties to 5-HT receptors. The patent aims to provide prevention and relief from migraine-related headaches, Parkinson's disease, and disorders of thrombocyte function, among other applications. He has 1 patent to his name.
Career Highlights
Sven Jaenichen is associated with Axxonis Pharma AG, a company dedicated to advancing pharmaceutical innovations. His work at Axxonis Pharma AG has positioned him as a key player in the development of new therapeutic methods.
Collaborations
Sven collaborates with talented individuals such as Jan Cvak and Erika Glusa, who contribute to the innovative environment at Axxonis Pharma AG. Their combined expertise fosters a culture of creativity and advancement in medical research.
Conclusion
Sven Jaenichen's contributions to migraine treatment through his patented methods highlight his role as an influential inventor in the pharmaceutical industry. His work continues to pave the way for new therapeutic options for patients suffering from migraines and related conditions.